ArticleCurrent protocols2026
Standardization of Immunohistochemistry Using an Anti-WASLB Antibody in the Skeletal Muscle of Teleost Fish.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Standardization of Immunohistochemistry Using an Anti-WASLB Antibody in the Skeletal Muscle of Teleost Fish.Current protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Immunohistochemistry (IHC) is a widely used technique for the identification, localization, and analysis of protein expression in tissues, playing a critical role in pathological diagnosis and validation of data derived from molecular biology. Despite its well-established use in mammalian tissues, applying IHC to fish still presents challenges, particularly due to the use of heterologous antibodies and the presence of paralogous genes. In this context, the present study aimed to standardize an immunohistochemistry protocol adapted for fish skeletal muscle using a biotinylated monoclonal antibody designed against a conserved region of the waslb gene for pacu (Piaractus mesopotamicus) and zebrafish (Danio rerio). Muscle samples were fixed in 4% paraformaldehyde, embedded in paraffin, and subjected to heat-induced antigen retrieval. After blocking nonspecific binding sites, histological sections were incubated with the primary antibody at an optimized 1:50 dilution, followed by detection with fluorophore-conjugated streptavidin (1:200) and nuclear counterstaining with DAPI. Reaction specificity was assessed using negative controls with a 20,000-fold molar excess of the immunizing peptide. The standardized protocol resulted in specific and reproducible labeling of the waslb protein in the skeletal muscle of both species, with no signal observed in negative controls; however, it is important to emphasize that this protocol can also be applied to antibodies against other fish genes. Thus, this method represents a reliable tool for protein analysis in fish muscle tissues, contributing to physiological, experimental, and comparative studies in non-mammalian models. © 2026 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol: Immunohistochemical reaction against the WASLB antibody in paraffin-embedded skeletal muscle sections of pacus and zebrafish.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.